Fisetin and resveratrol exhibit senotherapeutic effects and suppress cellular senescence in osteoarthritic cartilage-derived chondrogenic progenitor cells

  • 0Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.

|

|

Summary

This summary is machine-generated.

Fisetin and resveratrol, natural compounds, were found to suppress cellular senescence in knee osteoarthritis (OA) chondrogenic progenitor cells (CPCs). These senotherapeutics reduced senescence markers and inflammatory SASP factors, offering potential OA treatment strategies.

Area Of Science

  • Biomedical Science
  • Cell Biology
  • Osteoarthritis Research

Background

  • Articular cartilage in knee osteoarthritis (OA) patients features chondrogenic progenitor cells (CPCs) exhibiting cellular senescence and a senescence-associated secretory phenotype (SASP).
  • Cellular senescence contributes to OA pathogenesis, making it a target for therapeutic intervention.

Purpose Of The Study

  • To investigate the senotherapeutic potential of fisetin and resveratrol in suppressing cellular senescence in CPCs from OA patients.
  • To evaluate the effects of fisetin and resveratrol on senescence markers and SASP factors in OA-derived CPCs.

Main Methods

  • In vitro treatment of CPCs with varying concentrations of fisetin and resveratrol.
  • Assessment of cell viability, senescence index, and expression of senescence markers (p53, p38MAPK).
  • Analysis of SASP-related genes/proteins (MMP-9, MMP13) and inflammatory mediators (IL-1β, TGF-β, IL-6).
  • In silico molecular docking to confirm binding affinity to OA-related proteins.

Main Results

  • Fisetin and resveratrol were non-cytotoxic to CPCs at tested concentrations (5μM-100μM).
  • Both compounds significantly decreased the senescence index and downregulated p53 and p38MAPK expression.
  • Expression of SASP factors (MMP-9, MMP13) and inflammatory mediators (IL-1β, TGF-β, IL-6) was reduced.
  • In silico analysis supported the binding affinity of fisetin and resveratrol to OA-related targets.

Conclusions

  • Fisetin and resveratrol effectively dampen cellular senescence and reduce the SASP in OA-derived CPCs, primarily through p53 pathway modulation.
  • These natural compounds demonstrate potential as senotherapeutics for knee osteoarthritis, targeting cellular senescence and associated inflammation.

Related Concept Videos

Mesenchymal Stem Cells 01:19

4.6K

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Stem Cell Therapy for Tissue Regeneration 01:21

4.0K

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Replicative Cell Senescence 02:15

3.6K

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...